This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The contents of the 1935 volume of collected reports of the Council fall roughly into three classifications: preliminary and special reports, reports on the omission of products from New and Nonofficial Remedies, and reports on products held nonacceptable for N. N. R. The medicinal products concerned thus fall respectively into the following groups: products which have been considered and found promising but not as yet fully acceptable, products which have been accepted but have not continued to meet the standards of acceptability, and products which on initial or continued consideration have been found definitely unacceptable. It is understood, of course, that the term "acceptable" implies that the product has sufficient value or promise of value to be used by the general medical profession and further that it is marketed in accordance with the Council's rules.
The Council's preliminary reports cover the first line of therapeutic advance. In general these reports
Annual Reprint of the Reports of the Council on Pharmacy and Chemistry of the American Medical Association for 1935, with the Comments that Have Appeared in The Journal. JAMA. 1936;107(26):2156. doi:10.1001/jama.1936.02770520058029
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: